114 related articles for article (PubMed ID: 35395807)
1. Retraction Note: BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
Stem Cell Res Ther; 2022 Apr; 13(1):154. PubMed ID: 35395807
[No Abstract] [Full Text] [Related]
2. BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
Stem Cell Res Ther; 2019 Aug; 10(1):237. PubMed ID: 31387619
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway.
Guo J; Guo M; Zheng J
Cancer Manag Res; 2021; 13():773-785. PubMed ID: 33536785
[TBL] [Abstract][Full Text] [Related]
4. Anti-metastatic potential of a proton beam is regulated by p38 MAPK/c-Fos signaling pathway in TPA-treated HepG2 human hepatocellular carcinoma.
Chun SY; Kim S; Nam KS; Lee KS
Biomed Pharmacother; 2018 Mar; 99():904-912. PubMed ID: 29710490
[TBL] [Abstract][Full Text] [Related]
5. Resistomycin Induced Apoptosis and Cycle Arrest in Human Hepatocellular Carcinoma Cells by Activating p38 MAPK Pathway In Vitro and In Vivo.
Han Z; Zhao X; Zhang E; Ma J; Zhang H; Li J; Xie W; Li X
Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681182
[TBL] [Abstract][Full Text] [Related]
6. Exogenous NO induces apoptosis of hepatocellular carcinoma cells via positive p38/JNK signaling pathway and negative ERK signaling pathways.
Liu L; Xing Y; Cao M; Xu J; Chen J
Mol Cell Biochem; 2021 Apr; 476(4):1651-1661. PubMed ID: 33420899
[TBL] [Abstract][Full Text] [Related]
7. Cardiac myocyte p38α kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart.
Rose BA; Yokota T; Chintalgattu V; Ren S; Iruela-Arispe L; Khakoo AY; Minamisawa S; Wang Y
J Biol Chem; 2017 Aug; 292(31):12787-12800. PubMed ID: 28637870
[TBL] [Abstract][Full Text] [Related]
8. Hydrazinocurcumin Induces Apoptosis of Hepatocellular Carcinoma Cells Through the p38 MAPK Pathway.
He H; Qiao K; Wang C; Yang W; Xu Z; Zhang Z; Jia Y; Zhang C; Peng L
Clin Transl Sci; 2021 Sep; 14(5):2075-2084. PubMed ID: 32100959
[TBL] [Abstract][Full Text] [Related]
9. Polycyclic aromatic hydrocarbons induce migration in human hepatocellular carcinoma cells (HepG2) through reactive oxygen species-mediated p38 MAPK signal transduction.
Song MK; Kim YJ; Song M; Choi HS; Park YK; Ryu JC
Cancer Sci; 2011 Sep; 102(9):1636-44. PubMed ID: 21635667
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
11. Fuzheng Qingjie recipe induces apoptosis in HepG2 cells via P38 MAPK activation and the mitochondria-dependent apoptotic pathway.
Chen XZ; Li JN; Zhang YQ; Cao ZY; Liu ZZ; Wang SQ; Liao LM; Du J
Mol Med Rep; 2014 Jun; 9(6):2381-7. PubMed ID: 24737008
[TBL] [Abstract][Full Text] [Related]
12. [EphA2 mediated vascular endothelial growth factor expression via the p38 MAPK signaling pathway in squamous cell carcinoma of the head and neck].
Liu Y; Tan HL; Li G; Yu CY; Su ZW; Ren SL; Zhu GC; Qiu YZ; Tian YQ; Zhang X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Mar; 48(3):229-33. PubMed ID: 23755789
[TBL] [Abstract][Full Text] [Related]
13. Opposite effects of JNK and p38 MAPK signaling pathways on furazolidone-stimulated S phase cell cycle arrest of human hepatoblastoma cell line.
Sun Y; Tang S; Jin X; Zhang C; Zhao W; Xiao X
Mutat Res; 2013 Jul; 755(1):24-9. PubMed ID: 23660333
[TBL] [Abstract][Full Text] [Related]
14. S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
Int J Oncol; 2013 Mar; 42(3):1001-10. PubMed ID: 23354417
[TBL] [Abstract][Full Text] [Related]
15. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the p38 MAPK signaling pathway in S-phase cell-cycle arrest induced by Furazolidone in human hepatoma G2 cells.
Sun Y; Tang S; Jin X; Zhang C; Zhao W; Xiao X
J Appl Toxicol; 2013 Dec; 33(12):1500-5. PubMed ID: 23112108
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk mechanism between endothelial cells and hepatocellular carcinoma cells via growth factors and integrin pathway promotes tumor angiogenesis and cell migration.
Feng T; Yu H; Xia Q; Ma Y; Yin H; Shen Y; Liu X
Oncotarget; 2017 Sep; 8(41):69577-69593. PubMed ID: 29050226
[TBL] [Abstract][Full Text] [Related]
18. Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway.
Li L; Zheng BB; Ma LS; Sun X; Chang JJ; Xie WD; Li X
Acta Pharmacol Sin; 2014 Oct; 35(10):1311-22. PubMed ID: 25176399
[TBL] [Abstract][Full Text] [Related]
19. Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.
Gao Y; Lin LP; Zhu CH; Chen Y; Hou YT; Ding J
Cancer Biol Ther; 2006 Aug; 5(8):978-85. PubMed ID: 16855382
[TBL] [Abstract][Full Text] [Related]
20. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
